A single-nucleotide polymorphism in the p110β gene promoter is associated with partial protection from insulin resistance in severely obese adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 212-215

  Le Stunff, Catherine ^a   Dechartres, Agnès ^b   Del Giudice, Emanuele Miraglia ^c   Froguel, Philippe ^d   Bougnères, Pierre ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 38149009556     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1822     Document Type: Article

References (24)

1. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S 2002 Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
3. Bacha F, Saad R, Gungor N, Arslanian SA 2006 Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care 29:1599-1604
4. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S 2003 Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:951-957
5. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD 2001 Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17:615-675
6. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR 2002 Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22:965-977
7. Hooshmand-Rad R, Hajkova L, Klint P, Karlsson R, Vanhaesebroeck B, Claesson-Welsh L, Heldin CH 2000 The PI 3-kinase isoforms p110(α) and p110(β) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 113(Pt 2):207-214
8. Kossila M, Pihlajamaki J, Karkkainen P, Miettinen R, Kekalainen P, Vauhkonen I, Yla-Herttuala S, Laakso M 2003 Promoter polymorphisms -359T/C and -303A/G of the catalytic subunit p110β gene of human phosphatidylinositol 3-kinase are not associated with insulin secretion or insulin sensitivity in Finnish subjects. Diabetes Care 26:179-182
9. Le Stunff C, Fallin D, Schork NJ, Bougneres P 2000 The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nat Genet 26:444-446
10. Dina C, Meyre D, Samson C, Tichet J, Marre M, Jouret B, Charles MA, Balkau B, Froguel P 2007 A common genetic variant is associated with adult and childhood obesity. Science 315:187; author reply 187
11. Santoro N, Cirillo G, Amato A, Luongo C, Raimondo P, D'Aniello A, Perrone L, Miraglia del Giudice E 2006 Insulin gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhood obesity. J Clin Endocrinol Metab 91:4641-4644
12. Lubrano-Berthelier C, Le Stunff C, Bougneres P, Vaisse C 2004 A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J Clin Endocrinol Metab 89:2028-2032
13. Carel JC, Boitard C, Bougneres PF 1993 Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children. J Clin Invest 92:509-513
14. Tanner J 1962 Growth at adolescence. Oxford, UK: Blackwell Scientific
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
16. Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S 2004 Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89:1096-1101
17. Conwell LS, Trost SG, Brown WJ, Batch JA 2004 Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 27:314-319
18. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA 2003 Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 88:2534-2540
19. Asano T, Kanda A, Katagiri H, Nawano M, Ogihara T, Inukai K, Anai M, Fukushima Y, Yazaki Y, Kikuchi M, Hooshmand-Rad R, Heldin CH, Oka Y, Funaki M 2000 p110β is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity. J Biol Chem 275:17671-17676
20. Le Stunff C, Dechartes A, Mariot V, Lotton C, Trainor C, Miraglia Del Guidice E, Meyre D, Bieche I, Laurendeau I, Froguel P, Zelenika D, Fallin D, Lathrop M, Roméo PH, Bougnères P, Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a cis-acting expression quantitative trait locus (eQTL) for this gene and attenuates insulin resistance (IR) in obese children. Diabetes, in press
21. Abdul-Ghani MA, Tripathy D, DeFronzo RA 2006 Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130-1139
22. Barlow SE, Dietz WH 1998 Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102:E29
23. Jones KL 2002 Why test the children? Understanding insulin resistance, its complications, and its progression. Diabetes Care 25:2350-2351
24. Moonesinghe R, Khoury MJ, Janssens AC 2007 Most published research findings are false-but a little replication goes a long way. PLoS Med 4:e28